Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Alnylam Seeking Lumasiran Approvals Soon, But Has Two Rivals On Its Heels
Dec 18 2019
•
By
Mandy Jackson
Primary hyperoxaluria type 1 causes kidney stones and renal disease. • Source: Shutterstock
More from Clinical Trials
More from R&D